ganciclovir , an experimental agent , has shown promise against cytomegalovirus infections in patients who have undergone kidney or liver transplantation , but its effects are only temporary in patients who have undergone bone marrow transplantation and patients with acquired immunodeficiency syndrome ( aids ) who have cytomegalovirus infections .
C0017066
ganciclovir
C0010823
cytomegalovirus infections